Firegiant, I did not realize you were also an advocate for

New Post Public Reply Private Reply Replies (0) Message Board
Meach firegiant #669

Firegiant, I did not realize you were also an advocate for free speech and equality.  Hah

Today is the 31st of March.....Then June and July.....

Now we all have to realize with this time frame- that q3 (i think) starts soon... 
I mean, so long as these are not fiscal quarters, and these are calendar quarters....

A lot of people are ... in an ask about when exactly and what exactly this timeline means..... Hopefully this clears things up...

Q1= JAN FEB MAR
Q2=APR MAY JUN
Q3=JUL AUG SEP
Q4=OCT NOV DEC

EDIT: Lets put the timeline in these too..

Response to FDA questions is taking place Q3 2013..... That gives us a 3 month span....
JUL-AUG-SEP, 2013.  

Initiate HemaXellerate Trial;  Q4 2013 ( THIS IS WHERE WE MAKE LOOOOOOTS OF MONEY Q1 = FURY BUYS AND SELLS!)  OCT-NOV-DEC 2013.   (And then HemaXellerate should be done all of its trials roughly december 2015 (and as long as they are releasing PR's and everything is happening and going through clinical trials I will not care if they take a little longer at this phase, but that is for the future).)

  • In license Min technology: Q2 2013 (APR-MAY-JUN)
  • File IND on Min technology: Q4 2013  (OCT-NOV-DEC)
  • Initiate clinical trial on Min technology: Q4 2013 (OCT-NOV-DEC)


    Anything that is 2014 or later I do not care about because I'm already rich by then (If this really works out for me)
  • Response to FDA questions: Q3 2013
  • Initiate HemaXellerate trial: Q4 2013
  • Complete HemaXellerate trial: Q4 2014-Q2 2015
  • In license Min technology: Q2 2013
  • File IND on Min technology: Q4 2013
  • Initiate clinical trial on Min technology: Q4 2013
  • Complete clinical trial on Min technology: Q4 2014-Q2 2015

Definition of 'Quarter - Q1, Q2, Q3, Q4'

A three-month period on a financial calendar that acts as a basis for the reporting of earnings and the paying of dividends. A quarter refers to one-fourth of a year and is typically expressed as "Q." The four quarters that make up the year are: January, February and March (Q1); April, May and June (Q2); July, August and September (Q3); and October, November and December (Q4). A quarter is often shown with its relevant year, as in Q1 2012 or Q1/12, which represents the first quarter of the year 2012.

Investopedia explains 'Quarter - Q1, Q2, Q3, Q4'

All public companies in the United States must file quarterly reports (known as 10-Qs) with the U.S. Securities and Exchange Commission (SEC). Each 10-Q contains the public company's unaudited financial statements and company operations information for the previous three months (quarter). 10-Qs are required for the first three quarters of the year. Each publicly traded company must also file an annual report, known as a 10-K, which includes all of the quarters. 

Companies, investors and analysts use data from different quarters to make comparisons and evaluate trends. For instance, a retailer may compare this year's Q2 sales over last year's Q2 sales, or an analyst may evaluate a firm's earnings by reviewing data from the same quarter over several years.

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 83

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 84

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 124

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 46

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading

Top 5 Most Recently Viewed Articles

Disney Cruise Line Celebrates Employees as Godparents of Treasure

Updated Category News Views 97

Disney Cruise Line Celebrates Employees in Honor of Disney Treasure Disney Cruise Line is redefining maritime traditions in a beautiful manner by honoring its dedicated employees worldwide. The company’s latest announcement revealed that the honorific role of "godparent" for the new ship, the Disney Treasure, will be shared among its tremendous cast, crew, Imagineers,...

Continue Reading
Regional Management Corp. to Share Q3 2024 Financial Insights

Updated Category News Views 79

Regional Management Corp. to Announce Q3 Results Greenville, S.C. – Regional Management Corp. (NYSE: RM), a prominent player in the consumer finance sector, is set to share its financial results for the third quarter of 2024. Conference Call Details and Replay The company will report its quarterly results after market close, providing investors and stakeholders with...

Continue Reading
Suvoda Recognized as a Leader in Clinical Trial Technology

Updated Category News Views 147

Suvoda Acknowledged as a Leader in RTSM Technology Suvoda, a cutting-edge clinical trial technology company, recently shared exciting news about their IRT (Interactive Response Technology) software, which has been designated as a Leader in the prominent Everest Group's PEAK Matrix assessment for RTSM (Randomization and Trial Supply Management) technology. This recognition...

Continue Reading
Cereno Scientific Expands CS014 Focus to Combat PH-ILD

Updated Category News Views 131

Cereno Scientific Expands CS014 Focus to Combat PH-ILD Cereno Scientific, a pioneering biotech company, has made a significant announcement regarding the development focus of its HDAC inhibitor CS014. This innovative treatment is now targeting pulmonary hypertension associated with interstitial lung disease (PH-ILD), an area marked by a high level of unmet medical need....

Continue Reading
Dysmenorrhea Treatment Market Growth Insights for 2032

Updated Category News Views 188

Global Dysmenorrhea Treatment Market Insights Dysmenorrhea, commonly referred to as menstrual cramps, affects many women globally, causing significant discomfort during their menstrual cycles. Recent trends indicate that as awareness of this condition grows, so does the demand for effective treatments. The global dysmenorrhea treatment market is projected to surpass USD 8...

Continue Reading